pan-kras inhibitor aube00
Generic: Pan-KRAS Inhibitor AUBE00
pan-kras inhibitor aube00: 1 clinical trial tracked.
pan-kras inhibitor aube00 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about pan-kras inhibitor aube00, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase I Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Activity of AUBE00 in Patients With Solid Tumors
Primary endpoint: Adverse events of AUBE00 [Part A, B, C]
Interventionalopen130 targetStarted 2025-06Completion 2029-124 sites · Japan, United StatesChugai Pharmaceutical